Naveena B. Janakiram

Combination of Atorvastatin with Sulindac or Naproxen Profoundly Inhibits Colonic Adenocarcinomas by Suppressing the p65/β-Catenin/Cyclin D1 Signaling Pathway in Rats

Nanjoo Suh, Bandaru S. Reddy, Andrew DeCastro et al. · Cancer Prevention Research · 2011 · 66 citations · Full text

Inflammation, Tumor Biology, Molecular Pharmacology +14

Chemoprevention of Colon Carcinogenesis by Oleanolic Acid and Its Analog in Male F344 Rats and Modulation of COX-2 and Apoptosis in Human Colon HT-29 Cancer Cells

Naveena B. Janakiram, Indranie Cooma, Swamy V. Malisetty et al. · Pharmaceutical Research · 2008 · 60 citations

Colon Carcinogenesis, Male F344 Rats, Medicine +9

Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCMin/+ Mice by Licofelone, a Novel Dual 5-LOX/COX Inhibitor: Potential Implications for Human Colon Cancer Prevention

Altaf Mohammed, Naveena B. Janakiram, Qian Li et al. · Cancer Prevention Research · 2011 · 60 citations · Full text

Chemoprevention Strategy, Gastrointestinal Pharmacology, Potential Implications +18

Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer

Chinthalapally V. Rao, Naveena B. Janakiram, Venkateshwar Madka et al. · Cancer Research · 2016 · 58 citations · Full text

The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model

Altaf Mohammed, Naveena B. Janakiram, Qian Li et al. · Cancer Prevention Research · 2010 · 51 citations · Full text